• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

高覆盖率预防产前和产后 RhIg 的 RhD 免疫风险因素:一项全国性队列研究。

Risk factors for RhD immunisation in a high coverage prevention programme of antenatal and postnatal RhIg: a nationwide cohort study.

机构信息

Department of Obstetrics, Leiden University Medical Center, Leiden, the Netherlands.

Centre for Clinical Transfusion Research, Sanquin Research, Amsterdam, the Netherlands.

出版信息

BJOG. 2022 Sep;129(10):1721-1730. doi: 10.1111/1471-0528.17118. Epub 2022 Mar 18.

DOI:10.1111/1471-0528.17118
PMID:35133072
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9543810/
Abstract

OBJECTIVE

To evaluate which risk factors for RhD immunisation remain, despite adequate routine antenatal and postnatal RhIg prophylaxis (1000 IU RhIg) and additional administration of RhIg. The second objective was assessment of the current prevalence of RhD immunisations.

DESIGN

Prospective cohort study.

SETTING

The Netherlands.

POPULATION

Two-year nationwide cohort of alloimmunised RhD-negative women.

METHODS

RhD-negative women in their first RhD immunised pregnancy were included for risk factor analysis. We compared risk factors for RhD immunisation, occurring either in the previous non-immunised pregnancy or in the index pregnancy, with national population data derived from the Dutch perinatal registration (Perined).

RESULTS

In the 2-year cohort, data from 193 women were eligible for analysis. Significant risk factors in women previously experiencing a pregnancy of an RhD-positive child (n = 113) were: caesarean section (CS) (OR 1.7, 95% CI 1.1-2.6), perinatal death (OR 3.5, 95% CI 1.1-10.9), gestational age >42 weeks (OR 6.1, 95% CI 2.2-16.6), postnatal bleeding (>1000 ml) (OR 2.0, 95% CI 1.1-3.6), manual removal of the placenta (MRP) (OR 4.3, 95% CI 2.0-9.3); these factors often occurred in combination. The miscarriage rate was significantly higher than in the Dutch population (35% versus 12.-5%, P < 0.001).

CONCLUSION

Complicated deliveries, including cases of major bleeding and surgical interventions (CS, MRP), must be recognised as a risk factor, requiring estimation of fetomaternal haemorrhage volume and adjustment of RhIg dosing. The higher miscarriage rate suggests that existing RhIg protocols need adjustment or better compliance.

TWEETABLE ABSTRACT

Complicated delivery (caesarean section, manual removal placenta, major bleeding) is the most valid risk factor for RhD immunization despite antenatal and postnatal RhIg.

摘要

目的

评估在充分的常规产前和产后 RhIg 预防(1000IU RhIg)以及额外给予 RhIg 的情况下,哪些 RhD 免疫的风险因素仍然存在。第二个目的是评估当前 RhD 免疫的流行率。

设计

前瞻性队列研究。

地点

荷兰。

人群

两年内全国 RhD 阴性 alloimmunised 妇女队列。

方法

纳入首次 RhD 免疫妊娠的 RhD 阴性妇女进行危险因素分析。我们比较了在前次未免疫妊娠或指数妊娠中发生的 RhD 免疫的危险因素,并与来自荷兰围产期登记(Perined)的全国人群数据进行了比较。

结果

在 2 年队列中,有 193 名妇女的数据符合分析条件。在之前经历过 RhD 阳性胎儿妊娠的妇女(n=113)中,显著的危险因素是:剖宫产术(CS)(OR 1.7,95%CI 1.1-2.6)、围产期死亡(OR 3.5,95%CI 1.1-10.9)、妊娠年龄>42 周(OR 6.1,95%CI 2.2-16.6)、产后出血(>1000ml)(OR 2.0,95%CI 1.1-3.6)、手动胎盘剥离术(MRP)(OR 4.3,95%CI 2.0-9.3);这些因素经常同时发生。流产率明显高于荷兰人群(35%比 12.-5%,P<0.001)。

结论

复杂的分娩,包括大出血和手术干预(CS、MRP),必须被视为一个危险因素,需要估计胎儿母体出血的量并调整 RhIg 的剂量。较高的流产率表明现有的 RhIg 方案需要调整或更好的依从性。

可推文摘要

尽管有产前和产后 RhIg 预防,但复杂的分娩(剖宫产、手动胎盘剥离术、大出血)仍然是 RhD 免疫的最有效危险因素。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f411/9543810/bdc73d4a9458/BJO-129-1721-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f411/9543810/c9fbf6813019/BJO-129-1721-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f411/9543810/bdc73d4a9458/BJO-129-1721-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f411/9543810/c9fbf6813019/BJO-129-1721-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f411/9543810/bdc73d4a9458/BJO-129-1721-g001.jpg

相似文献

1
Risk factors for RhD immunisation in a high coverage prevention programme of antenatal and postnatal RhIg: a nationwide cohort study.高覆盖率预防产前和产后 RhIg 的 RhD 免疫风险因素:一项全国性队列研究。
BJOG. 2022 Sep;129(10):1721-1730. doi: 10.1111/1471-0528.17118. Epub 2022 Mar 18.
2
Risk factors for RhD immunisation despite antenatal and postnatal anti-D prophylaxis.尽管进行了产前和产后抗D预防,RhD免疫的危险因素。
BJOG. 2009 Sep;116(10):1307-14. doi: 10.1111/j.1471-0528.2009.02244.x. Epub 2009 Jun 17.
3
Cost-effectiveness of first trimester non-invasive fetal RHD screening for targeted antenatal anti-D prophylaxis in RhD-negative pregnant women: a model-based analysis.早孕期无创性胎儿 RhD 筛查用于 RhD 阴性孕妇靶向性产前抗 D 预防的成本效果分析:基于模型的分析。
BJOG. 2016 Jul;123(8):1337-46. doi: 10.1111/1471-0528.13801. Epub 2015 Dec 10.
4
Targeted routine antenatal anti-D prophylaxis in the prevention of RhD immunisation--outcome of a new antenatal screening and prevention program.目标性常规产前抗 D 预防措施在 RhD 免疫预防中的应用——一项新的产前筛查和预防计划的结果。
PLoS One. 2013 Aug 6;8(8):e70984. doi: 10.1371/journal.pone.0070984. Print 2013.
5
One single dose of 200 microg of antenatal RhIG halves the risk of anti-D immunization and hemolytic disease of the fetus and newborn in the next pregnancy.单次注射200微克产前Rh免疫球蛋白可将下一胎发生抗-D免疫和胎儿及新生儿溶血病的风险减半。
Transfusion. 2008 Aug;48(8):1721-9. doi: 10.1111/j.1537-2995.2008.01742.x. Epub 2008 May 23.
6
Costs and benefits of non-invasive fetal RhD determination.无创胎儿RhD血型测定的成本与效益
Ultrasound Obstet Gynecol. 2015 Jan;45(1):84-8. doi: 10.1002/uog.14723.
7
[Foetal Rhesus-D typing added to antenatal screening for infectious diseases and erythrocyte immunisation].[将胎儿恒河猴-D血型检测添加到产前传染病筛查和红细胞免疫检测中]
Ned Tijdschr Geneeskd. 2015;159:A8315.
8
Do chorionic villus samplings (CVS) or amniocenteses (AC) induce RhD immunisation? An evaluation of a large Danish cohort with no routine administration of anti-D after invasive prenatal testing.绒毛膜绒毛取样 (CVS) 或羊膜穿刺术 (AC) 是否会引起 RhD 免疫?一项对丹麦大型队列的评估,该队列在侵入性产前检测后没有常规给予抗-D。
BJOG. 2019 Nov;126(12):1476-1480. doi: 10.1111/1471-0528.15861. Epub 2019 Jul 25.
9
Economic analysis of foregoing Rh immunoglobulin for bleeding in pregnancy <12 weeks gestation.对于<12 周妊娠出血的 Rh 免疫球蛋白,不再进行经济学分析。
Contraception. 2024 Nov;139:110530. doi: 10.1016/j.contraception.2024.110530. Epub 2024 Jun 19.
10
Following targeted routine antenatal anti-D prophylaxis, almost half of the pregnant women had undetectable anti-D prophylaxis at delivery.在进行有针对性的常规产前抗-D 预防后,近一半的孕妇在分娩时抗-D 预防无法检测到。
Acta Obstet Gynecol Scand. 2022 Apr;101(4):431-440. doi: 10.1111/aogs.14328. Epub 2022 Feb 27.

引用本文的文献

1
Overview of detection methods of fetomaternal haemorrhage.母胎输血检测方法概述。
Front Physiol. 2025 Apr 11;16:1445757. doi: 10.3389/fphys.2025.1445757. eCollection 2025.
2
Design of a Phase 3, Global, Multicenter, Randomized, Placebo-Controlled, Double-Blind Study of Nipocalimab in Pregnancies at Risk for Severe Hemolytic Disease of the Fetus and Newborn.一项关于尼泊卡利单抗用于有胎儿及新生儿严重溶血病风险妊娠的3期全球多中心随机安慰剂对照双盲研究的设计
Am J Perinatol. 2025 May;42(7):842-853. doi: 10.1055/a-2404-8089. Epub 2024 Aug 28.
3
Red Blood Cell Alloimmunization in Pregnancy: A Review of the Pathophysiology, Prevalence, and Risk Factors.

本文引用的文献

1
Rhesus D alloimmunization in pregnancy from 1996 to 2015 in Iceland: a nation-wide population study prior to routine antenatal anti-D prophylaxis.1996 年至 2015 年冰岛妊娠期间的 RhD 同种异体免疫:常规产前抗 D 预防之前的全国性人群研究。
Transfusion. 2020 Jan;60(1):175-183. doi: 10.1111/trf.15635. Epub 2019 Dec 18.
2
"Provoked" feto-maternal hemorrhage may represent insensible cell exchange in pregnancies from 6 to 22 weeks gestational age.“诱发”的胎母出血可能代表妊娠 6 至 22 周时的不可感知的细胞交换。
Contraception. 2019 Aug;100(2):142-146. doi: 10.1016/j.contraception.2019.03.051. Epub 2019 Apr 11.
3
妊娠期红细胞同种免疫:病理生理学、患病率及危险因素综述
Cureus. 2024 May 12;16(5):e60158. doi: 10.7759/cureus.60158. eCollection 2024 May.
4
Pregnant women's knowledge and clinical management of hemolytic disease of the fetus and newborn in Pará, Brazil.巴西帕拉州孕妇对胎儿和新生儿溶血病的认知及临床管理
Hematol Transfus Cell Ther. 2024 Nov;46 Suppl 5(Suppl 5):S201-S207. doi: 10.1016/j.htct.2024.03.007. Epub 2024 May 25.
The near disappearance of fetal hydrops in relation to current state-of-the-art management of red cell alloimmunization.
当前红细胞同种免疫的先进管理使胎儿水肿近乎消失。
Prenat Diagn. 2018 Nov;38(12):943-950. doi: 10.1002/pd.5355. Epub 2018 Sep 27.
4
ACOG Practice Bulletin No. 192: Management of Alloimmunization During Pregnancy.美国妇产科医师学会临床实践公告第 192 号:孕期同种免疫的管理。
Obstet Gynecol. 2018 Mar;131(3):e82-e90. doi: 10.1097/AOG.0000000000002528.
5
Increasing incidence of postpartum hemorrhage: the Dutch piece of the puzzle.产后出血发病率上升:荷兰的情况
Acta Obstet Gynecol Scand. 2016 Oct;95(10):1104-10. doi: 10.1111/aogs.12950. Epub 2016 Aug 23.
6
Third trimester screening for alloimmunisation in Rhc-negative pregnant women: evaluation of the Dutch national screening programme.针对 Rhc 阴性孕妇同种免疫的孕晚期筛查:荷兰国家筛查项目的评估。
BJOG. 2016 May;123(6):955-63. doi: 10.1111/1471-0528.13816. Epub 2015 Dec 11.
7
Haemolytic disease of the fetus and newborn.胎儿和新生儿溶血病
Vox Sang. 2015 Aug;109(2):99-113. doi: 10.1111/vox.12265. Epub 2015 Apr 20.
8
Implementation of client versus care-provider strategies to improve external cephalic version rates: a cluster randomized controlled trial.实施产妇与医护人员策略以提高外倒转术成功率:一项整群随机对照试验
Acta Obstet Gynecol Scand. 2015 May;94(5):518-26. doi: 10.1111/aogs.12609. Epub 2015 Mar 29.
9
Trauma during pregnancy: a population-based analysis of maternal outcome.妊娠相关创伤:基于人群的母胎结局分析。
World J Surg. 2012 Dec;36(12):2767-75. doi: 10.1007/s00268-012-1750-6.
10
Fetomaternal hemorrhage in normal vaginal delivery and in delivery by cesarean section.正常阴道分娩和剖宫产术中的母婴出血。
Transfusion. 2012 Sep;52(9):1977-82. doi: 10.1111/j.1537-2995.2011.03536.x. Epub 2012 Feb 8.